| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC4149 | Physapubenolide | Natural cytotoxic withanolide antitumor agent, inducing apoptosis by decreasing mitochondrial membrane potential and elevating the Bax/Bcl-2 protein expression ratio |
|
| DCC4150 | Physodic Acid | Natural inhibitor of Wnt signaling, modulating β-catenin-dependent transcription |
|
| DCC4151 | Pi-090 | Platelet aggregation inhibitor |
|
| DCC4152 | Pi-091 | Platelet aggregation inhibitor |
|
| DCC4153 | Pi-2620 | Novel Tau ligand, displaying high Tau binding, low MAO-A binding, high brain uptake, and fast and complete brain washout |
|
| DCC4154 | Pi3k/akt/mtor-in-6be | Novel inhibitor of the PI3K/Akt/mTOR signaling pathways, activating P53 and inducing apoptosis |
|
| DCC4155 | Pi3k/akt-in-c89 | Novel Inhibitor of the PI3K-Akt Pathway, Inducing Autophagy of Female Germline Stem Cells |
|
| DCC4156 | Pi3kd/v-in-01 | Highly potent ATP-competitive PI3Kdelta/Vps34 dual inhibitor |
|
| DCC4157 | Pi3ki1 | Novel potent PI3K inhibitor with a modified omipalisib structure |
|
| DCC4158 | Pi3k-in-s1 | Novel PI3K inhibitor, synergizing with sorafenib in non-small cell lung cancer cells involving the Akt-S6 signaling. |
|
| DCC4159 | Piboserod Hydrochloride | Selective 5-HT4 receptor antagonist |
|
| DCC4160 | Picrasidine N | Novel Subtype-Selective PPARbeta/delta Agonist |
|
| DCC4161 | Picumeterol | Potent and selective beta2-adrenoceptor agonist |
|
| DCC4162 | Pikamilone Sodium | Prodrug of GABA, used for treatment of neurogenic bladder in spinal and benign prostatic hyperplasia |
|
| DCC4163 | Pik-c98 | Novel PI3K inhibitor, displaying potent preclinical activity against multiple myeloma |
|
| DCC4164 | Piloquinone | Natural activator of cryptic biosynthetic gene clusters (BGC), also acting as a potent inhibitor of monoamine oxidase B |
|
| DCC4165 | Pim-in-14j | Potent, highly selective, and orally bioavailable inhibitor of PIM-1 kinases |
|
| DCC4166 | Pim-in-a47 | Novel potent PIM inhibitor |
|
| DCC4167 | Pinoxepin Hydrochloride | Antipsychotic agent |
|
| DCC4168 | Pip4k-in-a131 | Inhibitor of PIP 4 Ks, efficiently killing transformed BJ cells, but not normal counterparts, displaying a strong selective lethality against Ras-activated or Ras-transformed cells |
|
| DCC4169 | Pipequaline Hydrochloride | Partial agonist of benzodiazepine receptors |
|
| DCC4170 | Piperacetazine | Antipsychotic prodrug, most notably used for schizophrenia |
|
| DCC4171 | Piperazinomycin | Antifungal antibiotic, showing inhibitory activity against fungi and yeasts, especially against Trichophyton |
|
| DCC4172 | Piperidol B2 | Novel potent in vitro and in vivo antifungal agent against azole-resistant Candida albicans |
|
| DCC4173 | Piperneolignan A | Natural nitric oxide (NO) production inhibitor |
|
| DCC4174 | Piroxicam-ß-cyclodextrin | NSAID with better gastrointestinal (GI) tolerability |
|
| DCC4175 | Pitofenone | Inhibitor of the acetylcholinesterase activity from bovine erythrocytes and electric eel |
|
| DCC4176 | Pixantrone | Inhibitor of topoisomerase II, intercalating into DNA and inducing topoisomerase II-mediated DNA strand crosslinks, resulting in inhibition of DNA replication and tumor cell cytotoxicity |
|
| DCC4177 | Pk5196 | Potent ligand to target the Y220C pocket, stabilizing Y220C |
|
| DCC4178 | Pkc-iota-in-19 | Novel Protein Kinase C-iota (PKC-ι) Inhibitor, Binding Post-kinase Domain Residues |
|
